Learning Objectives
Upon completion of this activity, participants should be able to:
Describe the results of recent studies of FDA-approved antiretroviral agents
Discuss the latest findings from studies of investigational antiretrovirals and treatment strategies
Review new data on HIV drug resistance and its clinical implications
CCO Expert Recap combining slides with audio commentary by Joseph J. Eron Jr, MD, and Daniel R. Kuritzkes, MD. CME credits will be available.